The American Heart Association, UPMC and Philips are teaming up in a $30 million venture capital fund to invest in heart disease and stroke care products.
Each organization is putting $10 million into the fund, called Cardeation Capital and managed by Aphelion Capital. They will invest the money in emerging healthcare companies' tools for preventing and treating cardiovascular disease, stroke and their risk factors.